The NKT cell ligand αgalactosylceramide suppresses allergic airway inflammation by induction of a Th1 response
Autor: | Knothe, S., Mutschler, V., Rochlitzer, S., Winkler, C., Ebensen, T., Guzman, C.A., Hohlfeld, J., Braun, A., Muller, M. |
---|---|
Zdroj: | In Vaccine 2011 29(25):4249-4255 |
Databáze: | ScienceDirect |
Externí odkaz: |